1. PRLog Home
  2. Business Index
  3. Pressroom Index
  4. Press Releases Home
  1. About
  2. Press Room
  3. Contact
Filter By Industry
Filter By Tag

Press Room

NAPSRx Press releases

1 - 10 of 231 Press Releases

Aug 28, 2014
Amgen is dedicated to discovering, developing, manufacturing and delivering innovative human therapeutics for patients with debilitating illnesses.

Aug 27, 2014
The U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Promacta® developed by GlaxoSmithKline (GSK) to treat a rare bone marrow disorder.

Aug 26, 2014
Roche looks to expand their respiratory portfolio by acquiring InterMune Inc, a California based biotechnology company and their lead product pirfenidone for idiopathic pulmonary fibrosis (IPF).

Aug 25, 2014
ViiV Healthcare is a global specialist company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) specializing in the treatment and care for people living with HIV.

Aug 22, 2014
Eliquis, a jointly developed therapy from Pfizer and Bristol-Myers Squibb has been approved by the FDA to treat deep vein thrombosis (DVT), pulmonary embolism (PE), and for the reduction in the risk of recurrent DVT and PE following initial therapy.

Aug 21, 2014
GlaxoSmithKline (GSK)– a world leader in the healthcare industry specializes in researching and developing vaccines, medicines and consumer healthcare products to improve people’s health and well-being.

Aug 20, 2014
Cerdelga™ is the only first-line oral therapy approved to treat adults with Type 1 Gaucher Disease, a rare genetic disorder that affects specific cells and organs in the body.

Aug 19, 2014
The investigational antibiotic CAZ-AVI was studied in patients with intra-abdominal infections (cIAI).

Aug 18, 2014
Based on favorable results obtained from the ADVANCE Phase 3 Study, the FDA approval of PLEGRIDY™ signifies a blockbuster therapeutic achievement for Biogen Idec .

Aug 15, 2014
Avastin becomes the first biologic medicine to approved in combination with chemotherapy to help women with advanced cervical cancer live longer.

RSS Feed for NAPSRx Press Releases